Solifenacin's IUPAC name is (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid 3-(1-azabicyclo[2.2.2]octan-3-yl) propyl ester. [1] This chemical name describes the precise arrangement of atoms and functional groups within the solifenacin molecule.
What is Solifenacin Used For?
Solifenacin is a medication used to treat the symptoms of overactive bladder (OAB). [2] It works by relaxing the bladder muscles, which helps to reduce the urgent need to urinate, frequent urination, and incontinence episodes associated with OAB. [3]
How Does Solifenacin Work?
Solifenacin is a competitive muscarinic receptor antagonist. [4] It primarily targets muscarinic M3 receptors, which are found in the detrusor muscle of the bladder. By blocking the action of acetylcholine at these receptors, solifenacin inhibits bladder muscle contractions, leading to increased bladder capacity and reduced urinary urgency. [5]
When Does Solifenacin's Patent Expiry Occur?
The patent expiry timeline for solifenacin, like many pharmaceuticals, can be complex due to various patents covering the active ingredient, formulations, and manufacturing processes. Detailed information regarding specific patent expiry dates for solifenacin can be found on platforms that track pharmaceutical intellectual property, such as DrugPatentWatch.com. [6]
What Are the Side Effects of Solifenacin?
Common side effects associated with solifenacin include dry mouth, constipation, blurred vision, and difficulty emptying the bladder. [7] Less common but more serious side effects can include urinary retention, confusion, and severe constipation. [8]
Are There Alternatives to Solifenacin for Overactive Bladder?
Several alternative treatment options exist for overactive bladder, including other medications with different mechanisms of action, such as antimuscarinics like oxybutynin or tolterodine, and beta-3 adrenergic agonists like mirabegron. [9] Behavioral therapies, such as bladder training and pelvic floor muscle exercises, are also common first-line treatments. [10]
How Does Solifenacin Compare to Other OAB Medications?
Solifenacin's efficacy and side effect profile are often compared to other OAB medications. While it generally offers effective symptom relief, individual responses and tolerability can vary. For instance, some patients may find solifenacin has a more favorable side effect profile regarding dry mouth compared to older antimuscarinics, though constipation remains a common concern. [11]
Who Manufactures Solifenacin?
Solifenacin is available under various brand names, with Vesicare being a prominent one. The manufacturer and availability can vary by region. [12] Generic versions of solifenacin are also available.
What Clinical Data Supports Solifenacin's Use?
Clinical trials have demonstrated solifenacin's effectiveness in reducing OAB symptoms, including decreasing the frequency of voids and incontinence episodes. [13] Studies have evaluated its impact on bladder capacity and patient-reported quality of life. [14]
Can Biosimilars of Solifenacin Be Developed?
As patents expire, the development of biosimilars for solifenacin becomes a possibility. Biosimilars are highly similar to an approved biologic product, offering comparable efficacy and safety. The regulatory pathways for approving biosimilars are distinct from those for small-molecule drugs. [15]
---
Sources:
1. https://pubchem.ncbi.nlm.nih.gov/compound/Solifenacin
2. https://www.nhs.uk/medicines/solifenacin/
3. https://www.mayoclinic.org/drugs-supplements/solifenacin-oral-route/proper-use/drg-20071978
4. https://www.drugbank.ca/drugs/DB00391
5. https://www.rxlist.com/vesicare-drug.htm
6. https://www.drugpatentwatch.com/
7. https://www.nhs.uk/medicines/solifenacin/side-effects-of-solifenacin/
8. https://www.mayoclinic.org/drugs-supplements/solifenacin-oral-route/side-effects/drg-20071978
9. https://www.auanet.org/guidelines/overactive-bladder
10. https://www.urologyhealth.org/urology-a-to-z/o/overactive-bladder-oab
11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114460/
12. https://www.webmd.com/drugs/2/drug-152412/solifenacin-oral-tablet
13. https://www.nejm.org/doi/full/10.1056/NEJMoa040047
14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3091268/
15. https://www.fda.gov/vaccines-blood/biosimilars/what-biosimilar